Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center. (2023)
Attributed to:
Development of AAV gene therapy for blindness caused by cone-rod dystrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biom13101484
PubMed Identifier: 37892166
Publication URI: http://europepmc.org/abstract/MED/37892166
Type: Journal Article/Review
Volume: 13
Parent Publication: Biomolecules
Issue: 10
ISSN: 2218-273X